Enterprise Value
$1.97 B
+$36.18 M+1.87%
Tue, 11 Mar 2025 23:59:45 GMT
Summary
- As of March 12, 2025, RXRX enterprise value is $1.97 billion, with a rise of +$36.18 million (+1.87%) during the most recent trading day.
- Over the past year, RXRX enterprise value has dropped by -$162.05 million (-7.60%).
- RXRX enterprise value is now -68.94% below its all-time high of $6.34 billion.
Performance
RXRX Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
RXRX Enterprise Value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | +1.9% | +1.5% | +1.5% |
| 1 m1 month | -23.6% | -19.8% | -19.8% |
| 3 m3 months | -26.3% | -18.4% | -20.6% |
| 6 m6 months | +38.3% | +35.8% | -4.7% |
| ytdytd | -10.7% | -8.8% | -10.0% |
| 1 y1 year | -7.6% | -0.7% | -42.0% |
| 5 y5 years | - | - | - |
RXRX Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -49.9% | $1.93 B | +1.9% | |
| 3 m | 3-month | $3.94 B | -49.9% | $1.93 B | +1.9% |
| 6 m | 6-month | $3.94 B | -49.9% | $1.39 B | +41.7% |
| 1 y | 1-year | $3.94 B | -49.9% | $1.30 B | +51.8% |
| 3 y | 3-year | $3.94 B | -49.9% | $411 M | +379.2% |
| 5 y | 5-year | $6.34 B | -68.9% | $411 M | +379.2% |
| alltime | all time | $6.34 B | -68.9% | $411 M | +379.2% |
Recursion Pharmaceuticals Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $1.97 B(-10.7%) |
| 2024 | $2.21 B(+10.6%) |
| Date | Value |
|---|---|
| 2023 | $1.99 B(+113.6%) |
| 2022 | $933.76 M(-64.7%) |
| 2021 | $2.64 B |
FAQ
- What is Recursion Pharmaceuticals enterprise value?
- What is the all time high enterprise value for Recursion Pharmaceuticals?
- What is RXRX enterprise value year-to-date change?
- What is Recursion Pharmaceuticals enterprise value year-on-year change?
What is Recursion Pharmaceuticals enterprise value?
The current enterprise value of RXRX is $1.97 B
What is the all time high enterprise value for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high enterprise value is $6.34 B
What is RXRX enterprise value year-to-date change?
Recursion Pharmaceuticals enterprise value has changed by -$236.11 M (-10.70%) since the beginning of the year
What is Recursion Pharmaceuticals enterprise value year-on-year change?
Over the past year, RXRX enterprise value has changed by -$162.05 M (-7.60%)